Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |